Skip to main content

Table 2 Response to treatment

From: Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma

 

Complete response (CR)

Partial response (PR)

Stable disease (SD)

Progression disease (PD)

TP + R

6 (16.7%)

12 (33.3%)

15 (41.7%)

3 (8.3%)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us